Prognostic implications and biological roles of EMT-related lncRNAs in lung squamous cell carcinoma: an in-depth analysis utilizing a novel prognostic signature and classification system
Jinming ZhangiD, Baihong ZhengiD, Xiuying ZhangiD, Ying LiuiD, Ying GuoiD, Jia Zhao, Jiamei LiuiD, Hui XueiD
Abstract
BackgroundLung squamous cell carcinoma (LUSC) represents a major subtype of non-small cell lung cancer (NSCLC), a leading contributor to cancer-related mortality. Epithelial-mesenchymal transition (EMT)-associated genes have been implicated in poor survival and metastatic gene expression in LUSC. Long non-coding RNAs (lncRNAs) are known to facilitate tumor progression and metastasis via EMT regulation. However, the prognostic significance and biological functions of EMT-associated lncRNAs in LUSC remain to be elucidated. MethodsIn this study, we aimed to develop an EMT-related lncRNA prognostic signature (EMT-LPS) utilizing RNA transcription data from LUSC patients in The Cancer Genome Atlas (TCGA) database, along with corresponding clinical characteristics. Kaplan-Meier analysis, receiver operating characteristic (ROC) curves, and Cox regression were employed to validate and assess the model. Furthermore, we confirmed the independent prognostic value of key genes in EMT-LPS using Gene Expression Profiling Interactive Analysis (GEPIA). Additionally, we proposed a novel LUSC classification system based on EMT-related lncRNA expression patterns, evaluating the prognostic profile, tumor microenvironment, and immunotherapy sensitivity of each subtype. ResultsA prognostic signature comprising twelve genes was constructed, and patients were stratified into high and low-risk groups according to their risk scores. Cox regression analysis revealed that the risk score served as an independent prognostic factor. A nomogram was generated to predict LUSC patient survival rates. Distinct subtypes exhibited varying tumor purity, immunogenicity, and immunotherapy drug sensitivity. ConclusionsOur findings underscore the relevance of EMT-related lncRNAs in LUSC and their potential utility in guiding immunotherapy strategies. The EMT-LPS and novel LUSC typing scheme provide a new perspective for understanding the biological functions and prognostic role of EMT-related lncRNAs in LUSC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development of a novel signature of long noncoding RNAs as a prognostic biomarker for esophageal cancer
Yan Miao, Jing Sui, … Lihong Yin·bioRxiv·Oct 13, 2018
- Partial epithelial-to-mesenchymal transition is prognostic and associates with Slug in head and neck cancer
H. Schinke, M. Pan, … O. Gires·bioRxiv·Oct 20, 2020
- A prognostic signature for lung adenocarcinoma in people who have never smoked
Wei Zhao, Tongwu Zhang, … Maria Teresa Landi·bioRxiv·Aug 13, 2025
- LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process
Linjun Liu, Wenjia Ren, … Yubai Zhou·PLoS ONEPeer-reviewed·Jun 29, 2023
- Tumor-suppressor signature for robust prognosis and prediction in adenocarcinoma non-small cell lung cancer
Man Jiang, Yuan-De Tan·bioRxiv·Mar 18, 2026
- An immune-lncRNA risk model to predict prognosis for patients with head and neck squamous cell carcinoma